FBInvestor
Stocks / Os Therapies Incorporated
Institutional Ownership

Os Therapies Incorporated

CUSIP 68764Y207COM NEWOSTXQ1 2026

13D / 13G Filings
9
Schedule 13D/13G on record
Beneficial Filers
4
Distinct reporting persons
Largest Stake
12.9%
Max % of class reported
Institutional Holders
26
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

9 filings · latest Aug 18, 2025

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Aug 18, 2025Shalom Auerbach13D/A8.5%SEC
2Aug 13, 2025Thomas A. Satterfield, Jr.13G/A11.0%3.12MSEC
3May 9, 2025Shalom Auerbach13D/A9.9%SEC
4Apr 16, 2025Ayala Pharmaceuticals, Inc.13G11.0%2.16MSEC
5Mar 12, 2025Shalom Auerbach13D/A12.9%SEC
6Feb 28, 2025Shalom Auerbach13D/A12.9%SEC
7Feb 12, 2025Thomas A. Satterfield, Jr.13G/A11.0%1.27MSEC
8Jan 17, 2025Shalom Auerbach13D11.9%SEC
9Aug 28, 2024Satterfield Thomas A Jr13G6.2%1.29MSEC

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →